SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-241075
Filing Date
2018-08-07
Accepted
2018-08-07 16:09:11
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d557514d10q.htm 10-Q 360761
2 EX-10.1 d557514dex101.htm EX-10.1 81571
3 EX-31.1 d557514dex311.htm EX-31.1 10406
4 EX-31.2 d557514dex312.htm EX-31.2 10240
5 EX-32.1 d557514dex321.htm EX-32.1 3611
6 EX-32.2 d557514dex322.htm EX-32.2 3595
  Complete submission text file 0001193125-18-241075.txt   2824544

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cprx-20180630.xml EX-101.INS 489235
8 XBRL TAXONOMY EXTENSION SCHEMA cprx-20180630.xsd EX-101.SCH 40788
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20180630_cal.xml EX-101.CAL 49999
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20180630_def.xml EX-101.DEF 110759
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20180630_lab.xml EX-101.LAB 300641
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20180630_pre.xml EX-101.PRE 202838
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 18998036
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences